Ada Bertoli

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Michela Violin, Alessandro Cozzi‐Lepri, Rossella Velleca et al. · AIDS · 2004 · 117 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug‐Naive Patients Treated with Protease Inhibitor–Based Therapy

Carlo Federico Perno, Alessandro Cozzi‐Lepri, Claudia Balotta et al. · The Journal of Infectious Diseases · 2001 · 112 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Variable Prediction of Antiretroviral Treatment Outcome by Different Systems for Interpreting Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance

Andrea De Luca, Antonella Cingolani, Simona Di Giambenedetto et al. · The Journal of Infectious Diseases · 2003 · 95 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection

Valentina Svicher, Valeria Cento, Martina Bernassola et al. · Antiviral Research · 2011 · 91 citations · Full text

Veterinary Medicine, Infectious Diseases, Early Detection +12

Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies

Velia Chiara Di Maio, Valeria Cento, Ilaria Lenci et al. · Liver International · 2017 · 90 citations · Full text

Life Sciences, Infectious Diseases, Clinical Pharmacology +11